Clinical Trial Update: Impact of HLA Evolutionary Divergence and HLA Donor-recipient Molecular Mismatches on Kidney Allograft Rejection

View source ↗

Summary

A completed clinical trial evaluates whether HLA evolutionary divergence and donor–recipient molecular mismatches influence kidney allograft rejection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Snippet

Sponsor: Paris Translational Research Center for Organ Transplantation | Conditions: Kidney Transplantation | Status: COMPLETED